Q2 2025 Earnings Call Transcript August 7, 2025 AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.12, ...

Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Welcome to the Lisata Therapeutics Second Quarter 2025 Financial ...

Rowan University and Sentrimed, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced results from a National Cancer Institute (NCI) ...

Significant regulatory advances for lead candidate EB613 streamline Phase 3 clinical development and reduce regulatory hurdles. These 10 stocks could mint the next wave of millionaires › Entera Bio ...

Key Points GAAP earnings per share of $(1.99) for Q2 2025 missed analyst estimates by $0.07. Net loss attributable to common stockholders (GAAP) narrowed to $5.7 million for Q2 2025, down from $7.4 ...